Kawasaki disease
Kawasaki disease, also known as mucocutaneous lymph node syndrome (MCLS), is an acute febrile rash disease in children with systemic vasculitis as the main lesion. It was first reported by Japanese doctor Tomisaku Kawasaki in 1967. Since this disease can cause serious cardiovascular lesions, it has attracted people's attention. The incidence has increased in recent years. In 1990, among the inpatients with rheumatic diseases in Beijing Children's Hospital, there were 67 cases of Kawasaki disease and 27 cases of rheumatic fever; in the same data from 11 hospitals in other provinces and cities, Kawasaki disease was twice that of rheumatism. Obviously, Kawasaki disease has replaced rheumatic fever as one of the main causes of acquired heart disease in children in my country. Kawasaki disease is currently considered to be an immune-mediated vasculitis.
-
Site of disease:
Skin lymphatic heart -
Infectious :
Not contagious -
Frequent population:
Infants and young children -
Related symptoms:
Fever rash conjunctival congestion cervical lymphadenopathy persistent fever -
Concurrent disease:
Related Drugs
aspirin
Indication: 1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.
aspirin
Indication: 1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.
Manufacturer:
Hunan Middle-South Pharmaceutical Co., Ltd.
aspirin
Indication: 1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.
Manufacturer:
Nanjing Pharmaceutical FACTORY Co., Ltd.
aspirin
Indication: 1. Analgesic and antipyretic; 2. Anti-inflammatory and anti-rheumatic; 3. Arthritis; 4. Anti-thrombotic; 5. Mucocutaneous lymph node syndrome (Kawasaki disease); 6. Prevention of gastrointestinal tumors; 7. Inhibition of platelet aggregation.
Tianqi Dieda Pills
Manufacturer:
Jiangxi Minji Pharmaceutical Co., Ltd.
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Hualan Biological Engineering,Inc.
Lyophilized human immunoglobulin for intravenous injection (pH4)
Indication: 1. Primary immunoglobulin deficiency such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Human immunoglobulin
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura and Kawasaki disease.
Manufacturer:
Shenzhen Weiguang Biological Products Co., Ltd.
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Yuanda Shuyang Life Science (Chengdu) Co., Ltd.
Intravenous human immunoglobulin (pH4)
Indication: 1. Primary immunoglobulin deficiency, such as X-linked hypoimmunoglobulinemia, common variable immunodeficiency, immunoglobulin G subtype deficiency, etc. 2. Secondary immunoglobulin deficiency, such as severe infection, neonatal sepsis, etc. 3. Autoimmune diseases, such as idiopathic thrombocytopenic purpura, Kawasaki disease.
Manufacturer:
Green Blood Products (Liaoning) Co., Ltd.
Related Ingredients
-
Acetylsalicylic acid list
50-78-2 -
Chrysophanic acid list
481-74-3 -
OLIBANUM GUM list
8050-07-5 -
MYRRH GUM list
9000-45-7